Publications by authors named "Paul Mutani"

Claim this Profile
M
Memory B-cells elicited by different HPV vaccine regimens in the DoRIS randomised controlled trial.
Rebecca Wiggins, Kathy J Baisley, Jackton Indangasi, John Changalucha, Helen Ashwin, Paul Mutani

NPJ Vaccines· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durability of immunogenicity at 5 years after a single dose of human papillomavirus vaccine compared with two doses in Tanzanian girls aged 9-14 years: results of the long-term extension of the DoRIS randomised trial.
Deborah Watson-Jones, John Changalucha, Caroline Maxwell, Hilary Whitworth, Paul Mutani

Lancet Glob Health· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose in young women aged 15-20 years in Kenya (KEN SHE): an immunobridging analysis of randomised controlled trials.
Kathy Baisley, Troy J Kemp, Nelly R Mugo, Hilary Whitworth, Maricianah A Onono, Paul Mutani

Lancet Glob Health· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial.
Deborah Watson-Jones, John Changalucha, Hilary Whitworth, Ligia Pinto, Paul Mutani

Lancet Glob Health· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial.
Kathy Baisley, Troy J Kemp, Aimée R Kreimer, Partha Basu, John Changalucha, Paul Mutani

Lancet Glob Health· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controlled human malaria infection of Tanzanians by intradermal injection of aseptic, purified, cryopreserved Plasmodium falciparum sporozoites.
Seif Shekalaghe, Mastidia Rutaihwa, Peter F Billingsley, Mwajuma Chemba, Claudia A Daubenberger, Paul Mutani

Am J Trop Med Hyg· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.

N Engl J Med· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis